全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1345675-02-6 | alpha,alpha-Dimethyl-4-[2-oxo-9-(3-quinolinyl)-2H-[1,3]oxazino[5,4-c]quinolin-1(4H)-yl]-benzeneacetonitrile | C30H22N4O2 |
| 1345681-71-1 | 35-Amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontan-1-ol | C24H51NO12 |
| 1345697-13-3 | tert-butyl (3S)-3-fluoro-3-(hydroxymethyl)piperidine-1-carboxylate | C11H20FNO3 |
| 1345808-25-4 | (alphaR)-alpha-Amino-alpha-(4-boronobutyl)-1-piperidinebutanoic acid;Arginase inhibitor 1 | C13H27BN2O4 |
| 1345822-86-7 | 5-Desfluoro Sitagliptin;(3R)-3-amino-4-(2,4-difluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one;phosphoric acid | C16H19F5N5O5P |
| 1345822-87-8 | 4-Desfluoro Sitagliptin;(3R)-3-amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one;phosphoric acid | C16H19F5N5O5P |
| 1345823-20-2 | 2-[5-[1,3-Dihydro-3,3-dimethyl-1-[6-oxo-6-(2-propyn-1-ylamino)hexyl]-5-sulfo-2H-indol-2-ylidene]-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-3H-indolium inner salt | C36H43N3O7S2 |
| 1345847-93-9 | Altiratinib;DCC 2701; DP 5164 | C26H21F3N4O4 |
| 1345866-68-3 | 4-(1,2,4,5-Tetrazin-3-yl)benzenemethanamine hydrochloride (1:?) | C9H9N5.x(HCl) |
| 1345887-44-6 | (S)-RuCl[(p-cyMene)(DM-BINAP)]Cl | |
| 1345966-78-0 | (4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone | C21H23NO2 |
| 1345969-99-4 | 9-(2,3,5-Tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purin-2-amine | C32H27N5O7 |
| 1345970-42-4 | RCS-8 | C25H29NO2 |
| 1345973-49-0 | 1-Pentyl-3-(adamant-1-oyl)indole;(1-Pentyl-1H-indol-3-yl)tricyclo[3.3.1.1(3,7)]dec-1-ylmethanone | C24H31NO |
| 1345973-53-6 | 1-Pentyl-N-tricyclo[3.3.1.1(3,7)]dec-1-yl-1H-indazole-3-carboxamide | C23H31N3O |
| 1345982-69-5 | Linerixibat;3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1?6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid | C28H38N2O7S |
| 1346007-02-0 | 2-(9,9-Dimethyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C21H25BO2 |
| 1346007-05-3 | 4,4,5,5-Tetramethyl-2-(9,9'-spirobi[9H-fluoren]-3-yl)-1,3,2-dioxaborolane | C31H27BO2 |
| 1346233-68-8 | 3,5-Dichloro-N-[[(1alpha,5alpha,6-exo, 6alpha)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide | C19H26Cl2N2O |
| 1346238-10-5 | Febuxostat Isopropyl Ester;Isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | C19H22N2O3S |
| 1346242-81-6 | Erdafitinib;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine | C25H30N6O2 |
| 1346528-06-0 | 2-(2,3-Dihydro-4H-1,4-benzoxazin-4-yl)-5,6,7,8-tetrahydro-N-(phenylmethyl)-4-quinazolinamine | C23H24N4O |
| 1346528-50-4 | N-(4-Chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-1-piperazinecarboxamide | C18H17ClF2N4O3 |
| 1346536-47-7 | 4-(Difluoromethyl)-2-pyridinamine;4-(Difluoromethyl)pyridin-2-amine | C6H6F2N2 |
| 1346546-69-7 | N-5-Benzothiazolyl-6-[(1-methylethyl)sulfonyl]-4-quinolinamine;GSK'872 | C19H17N3O2S2 |
| 1346547-00-9 | 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine | C20H19FN4O2S |
| 1346572-63-1 | N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide | C31H38N6O2 |
| 1346574-54-6 | (S)-6-Bromo-1-(sec-butyl)-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-1H-indole-4-carboxamide | C22H26BrN3O2 |
| 1346574-57-9 | GSK 126;N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-((1S)-1-methylpropyl)-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide | C31H38N6O2 |
| 1346597-50-9 | Ethyl N-tert-butoxycarbonyl-2-thiomorpholinecarboxylate;2,4-Thiomorpholinedicarboxylic acid 4-(1,1-dimethylethyl) 2-ethyl ester | C12H21NO4S |
| 1346597-52-1 | 2-Methoxy-alpha-oxo-5-pyrimidineacetic acid ethyl ester | C9H10N2O4 |
| 1346597-53-2 | 2-[2-Fluoro-4-(methylsulfonyl)phenyl]-1,3-dioxolane | C10H11FO4S |
| 1346597-58-7 | N-[2-(1,3-Dioxolan-2-yl)phenyl]carbamic acid phenylmethyl ester | C17H17NO4 |
| 1346597-81-6 | Bupivacaine N-Oxide HCl | C18H28N2O2 |
| 1346597-97-4 | rac-trans-4-Defluoro-4-ethoxy Paroxetine Hydrochloride;(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-ethoxyphenyl)piperidine;hydrochloride | C21H26ClNO4 |
| 1346598-11-5 | Domperidone EP Impurity B;4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine | C13H14ClN3O2 |
| 1346598-86-4 | Sodium (3R,5R)-7-[2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate | C33H34FN2NaO5 |
| 1346599-09-4 | 1-[3-(Methylamino)-1-(2-thienyl)propyl]-2-naphthalenol | C18H19NOS |
| 1346600-38-1 | rac Dehydro-O-desmethyl Venlafaxine;4-[1-(cyclohexen-1-yl)-2-(dimethylamino)ethyl]phenol | C16H23NO |
| 1346600-40-5 | 3-Fluoroephedrone Hydrochloride | C10H13ClFNO |
| 1346600-85-8 | Zolpidem EP Impurity A;6-(Desmethyl)-7-methyl zolpidem | C19H21N3O |
| 1346601-03-3 | 3-Indoxyl Sulfate-d4 Potassium Salt | C8H2D4KNO4S |
| 1346601-52-2 | 4-Methyl Erlotinib;4-Methyl Erlotinib Hydrochloride | C23H25N3O4 |
| 1346601-75-9 | Bisoprolol EP Impurity N;1-[4-(2-ethoxyethoxymethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol | C17H29NO4 |
| 1346601-76-0 | N-Formyl Oxcarbazepine | C16H12N2O3 |
| 1346602-28-5 | Risperidone EP Impurity E;6-Methylrisperidone;3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2,6-dimethyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | C24H29FN4O2 |
| 1346603-25-5 | rel-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1) | C21H24FN3O4.HCl |
| 1346603-41-5 | N-Nitrosodiethylamine-d4;N-ethyl-N-(1,1,2,2-tetradeuterioethyl)nitrous amide | C4D4H6N2O |
| 1346604-13-4 | Allopurinol EP Impurity C;5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide | C6H6N6O |
| 1346604-18-9 | Oseltamivir EP Impurity D;Ethyl 4-acetamido-3-hydroxybenzoate | C11H13NO4 |